Avenue Therapeutics Inc.

NASDAQ: ATXI · Real-Time Price · USD
0.50
-0.04 (-7.41%)
At close: Aug 11, 2025, 11:48 AM

Avenue Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-11.28M -14.54M -8.04M -3.74M
Interest Income
-176K 126K 20K 7K
Pretax Income
-11.65M -10.49M -3.6M -3.73M
Net Income
-11.65M -10.38M -3.55M -3.73M
Selling & General & Admin
4.64M 4.18M 5.34M 2.48M
Research & Development
6.64M 10.36M 2.7M 1.25M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
11.28M 14.54M 8.04M 3.74M
Interest Expense
n/a n/a 1.16M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 14.54M 8.04M 3.74M
Income Tax Expense
n/a n/a n/a -7K
Shares Outstanding (Basic)
12.95M 141K 29.14K 1.13M
Shares Outstanding (Diluted)
12.95M 141.22K 29.14K 1.13M
EPS (Basic)
-0.9 -73.6 -1.63 -3.29
EPS (Diluted)
-0.9 -73.48 -1.63 -3.29
EBITDA
-11.28M 4.05M -8.02M -3.73M
EBIT
n/a -10.49M -3.6M -3.73M
Depreciation & Amortization
n/a 14.54M 8.04M 3.74M